Principal Technologies, Inc. engages in the operations in healthcare technology including the project management of international scale clinical studies primarily related to medical device technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-11-01. The firm is engaged in building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. The firm operates through the health-care technology segment, including the project management of international scale clinical studies primarily related to medical device technologies. Its subsidiaries include Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH.
최신 재무제표(Form-10K)에 따르면, Principal Technologies Inc의 총 자산은 $1이며, 순손실입니다.
PTEKF의 주요 재무 비율은 무엇인가요?
Principal Technologies Inc의 유동비율은 1이고, 순이익률은 0, 주당 매출은 $0입니다.
Principal Technologies Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Principal Technologies Inc 주요 수익원은 Investment and Related Activities이며, 최신 수익 발표에서 수익은 1,273,000입니다. 지역별로는 United Kingdom이 Principal Technologies Inc의 주요 시장이며, 수익은 1,273,000입니다.
Principal Technologies Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Principal Technologies Inc의 순손실은 $-4입니다.